Patents by Inventor Mateusz PITAK

Mateusz PITAK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline solids of nicotinic acid mononucleotide and esters thereof and methods of making and use
    Patent number: 11952396
    Abstract: The present disclosure relates to crystalline solids comprising a compound of Formula (I), wherein R is n-propyl, and methods of making compounds of Formula (I) wherein R is C1-C4 alkyl or C2-C4 alkenyl. The present disclosure also relates to crystalline solids comprising a compound of Formula (II), The present disclosure further relates to methods of preparing the crystalline solids, and pharmaceutical preparations of the crystalline solids, and use of such pharmaceutical preparations in treatment of diseases and conditions.
    Type: Grant
    Filed: November 22, 2023
    Date of Patent: April 9, 2024
    Assignee: Metro International Biotech, LLC
    Inventors: Jonathan N. Kremsky, Bruce Szczepankiewicz, Karsten Koppetsch, Joseph Harris, Mateusz Pitak, Martin Bates
  • CRYSTALLINE SOLIDS OF NICOTINIC ACID MONONUCLEOTIDE AND ESTERS THEREOF AND METHODS OF MAKING AND USE
    Publication number: 20240109932
    Abstract: The present disclosure relates to crystalline solids comprising a compound of Formula (I), wherein R is n-propyl, and methods of making compounds of Formula (I) wherein R is C1-C4 alkyl or C2-C4 alkenyl. The present disclosure also relates to crystalline solids comprising a compound of Formula (II), The present disclosure further relates to methods of preparing the crystalline solids, and pharmaceutical preparations of the crystalline solids, and use of such pharmaceutical preparations in treatment of diseases and conditions.
    Type: Application
    Filed: November 22, 2023
    Publication date: April 4, 2024
    Inventors: Jonathan N. Kremsky, Bruce Szczepankiewicz, Karsten Koppetsch, Joseph Harris, Mateusz Pitak, Martin Bates
  • Crystalline solids of nicotinic acid mononucleotide and esters thereof and methods of making and use
    Patent number: 11787830
    Abstract: The present disclosure relates to crystalline solids comprising a compound of Formula (I), wherein R is n-propyl, and methods of making compounds of Formula (I) wherein R is C1-C4 alkyl or C2-C4 alkenyl. The present disclosure also relates to crystalline solids comprising a compound of Formula (II), The present disclosure further relates to methods of preparing the crystalline solids, and pharmaceutical preparations of the crystalline solids, and use of such pharmaceutical preparations in treatment of diseases and conditions.
    Type: Grant
    Filed: March 31, 2023
    Date of Patent: October 17, 2023
    Assignee: Metro International Biotech, LLC
    Inventors: Jonathan N. Kremsky, Bruce Szczepankiewicz, Karsten Koppetsch, Joseph Harris, Mateusz Pitak, Martin Bates
  • CRYSTALLINE SOLIDS OF NICOTINIC ACID MONONUCLEOTIDE AND ESTERS THEREOF AND METHODS OF MAKING AND USE
    Publication number: 20230257412
    Abstract: The present disclosure relates to crystalline solids comprising a compound of Formula (I), wherein R is n-propyl, and methods of making compounds of Formula (I) wherein R is C1-C4 alkyl or C2-C4 alkenyl. The present disclosure also relates to crystalline solids comprising a compound of Formula (II), The present disclosure further relates to methods of preparing the crystalline solids, and pharmaceutical preparations of the crystalline solids, and use of such pharmaceutical preparations in treatment of diseases and conditions.
    Type: Application
    Filed: March 31, 2023
    Publication date: August 17, 2023
    Inventors: Jonathan N. Kremsky, Bruce Szczepankiewicz, Karsten Koppetsch, Joseph Harris, Mateusz Pitak, Martin Bates
  • COMPLEXES
    Publication number: 20220356200
    Abstract: A compound of formula (I) wherein M is Pd(II) or Ni(II); X is a halide; R1 and R2 are independently organic groups having 1-20 carbon atoms, or R1 and R2 are linked to form a ring structure with the phosphorus atom; R3 is an organic group having 1-20 carbon atoms; provided that R1, R2, R3 are not each phenyl.
    Type: Application
    Filed: August 3, 2020
    Publication date: November 10, 2022
    Inventors: Rachel KAHAN, Mateusz PITAK, Carin SEECHURN
  • MONOHYDRATE AND CRYSTALLINE FORMS OF 6-[(3S,4S)-4-METHYL-1-(PYRIMIDIN-2-YLMETHYL)PYRROLIDIN-3-YL]-3-TETRAHYDROPYRAN-4-YL-7H-IMIDAZO[1,5-A]PYRAZIN-8-ONE
    Publication number: 20210107911
    Abstract: The present disclosure relates to crystalline polymorph forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazol[1,5-a]pyrazin-8-one.
    Type: Application
    Filed: December 2, 2020
    Publication date: April 15, 2021
    Inventors: Suzanne BUTTAR, Mateusz PITAK, Adam Ross PATTERSON, Samuel Alexander STRATFORD, Ioana SOVAGO, Jun XU, Peng ZHOU, Haojuan WEI, Kuangchu DAI